Medical Professional financing for your medical practice! Learn how to get funding with medical practice financing. More Info Here!
Call: 904-551-6090
Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.
Read The Interesting Snippets Below For Exciting Health-Care News!
Roche eye drug shows benefit in mid-stage trial
– http://www.reuters.com
ZURICH, Aug 27 (Reuters) – Roche’s experimental eye drug helped slow the progression of an advanced form of age-related macular degeneration (AMD), the drugmaker said on Tuesday, potentially boosting its chances in the lucrative eye drug market.
Continue Reading On http://www.reuters.com »Very early preemies face neurodevelopmental risks
– http://www.reuters.com/healthNews
NEW YORK (Reuters Health) – Babies who are born at 25 weeks’ gestation or earlier and survive early life have a “substantial likelihood” of having a very low IQ or other neurodevelopmental problems in childhood, researchers said today.
Continue Reading On http://www.reuters.com/healthNews »
Aug 27 (Reuters) – Johnson & Johnson said on Tuesday that the business heads of its three Chinese operations would start reporting to one chairman there next month in an effort to increase sales in that country.
Continue Reading On http://www.reuters.com »
Aug 27 (Reuters) – Specialty pharmaceutical company Akorn Inc will buy rival Hi-Tech Pharmacal Co Inc for $640 million in cash to expand its eye drug portfolio to other dosage forms such as oral liquids, topical creams and ointments.
Continue Reading On http://www.reuters.com »
FRANKFURT (Reuters) – Bayer’s cancer drug Nexavar was given priority review status by U.S. healthcare regulators for the oral drug’s use against a difficult-to-treat type of thyroid cancer, the company said on Tuesday.
Continue Reading On http://www.reuters.com/healthNews »
(Reuters) – Investors reacted favorably on Monday to Amgen Inc’s $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world’s largest biotech company full rights to a blood cancer drug with multibillion-dollar sales potential.
Continue Reading On http://www.reuters.com/healthNews »
Medical Practice Financing!
No down payment medical, dental and healthcare provider practice financing here! + More News: Very early preemies face neurodevelopmental risks + MORE 08/27/2013
No comments:
Post a Comment